# Connectomic Targeted TMS Target for Refractory Anxiety

> **NCT06376877** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Anxiety Disorders
- Mental Disorder
- Psychiatric Disorder

## Interventions

- **PROCEDURE:** Transcranial magnetic stimulation
- **PROCEDURE:** Sham transcranial magnetic stimulation

## Key facts

- **NCT ID:** NCT06376877
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2028-08-01
- **Final completion:** 2029-02-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06376877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06376877, "Connectomic Targeted TMS Target for Refractory Anxiety". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06376877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*